Spravato (56 MG Dose) and Tofacitinib Extended-Release Tablets
Determining the interaction of Spravato (56 MG Dose) and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esketamine
Brand name: Spravato
Synonyms: Spravato Nasal Spray, Spravato
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Spravato (56 MG Dose)-Tofacitinib Tablets
- Spravato (56 MG Dose)-Tofranil
- Spravato (56 MG Dose)-Tofranil injection
- Spravato (56 MG Dose)-Tofranil-PM
- Spravato (56 MG Dose)-Tol-Tab
- Spravato (56 MG Dose)-Tolazamide
- Tofacitinib Extended-Release Tablets-Spravato (84 MG Dose)
- Tofacitinib Extended-Release Tablets-Sprintec
- Tofacitinib Extended-Release Tablets-Sprintec 28
- Tofacitinib Extended-Release Tablets-Spritam
- Tofacitinib Extended-Release Tablets-Sprix
- Tofacitinib Extended-Release Tablets-Sprix Nasal Spray